![Miao Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Miao Liu
Gründer bei MingMed Biotechnology Co., Ltd.
Aktive Positionen von Miao Liu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Direktor/Vorstandsmitglied | 10.02.2021 | - |
Geschäftsführer | 25.11.2019 | - | |
Gründer | 25.11.2019 | - |
Karriereverlauf von Miao Liu
Ausbildung von Miao Liu
Peking University | Undergraduate Degree |
Statistik
International
China | 3 |
Operativ
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |